中文名稱:14,15-Leukotriene E4 | 英文名稱:14,15-Leukotriene E4 |
CAS:1000852-57-2 | 品牌: 一研 |
保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
Cas : 1000852-57-2 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
14,15-Leukotriene E4 | 25μg 50μg 100μg | 1000852-57-2 | EY-Y016458 |
Cas No.1000852-57-2
別名 N/A
化學名 N/A
分子式 C23H37NO5S
分子量 439.6
溶解度 DMF: > 50mg/ml,DMSO: > 50mg/ml,Ethanol: > 50mg/ml,PBS (pH 7.2): > 100μ g/ml
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
Leukotrienes (LTs) are a group of acute inflammatory mediators derived from arachidonic acid in leukocytes. The majority of these metabolites are formed through the 5-lipoxygenase (5-LO) pathway. 14,15-LTE4 is a metabolite of 14,15-LTC4 and 14,15-LTD4, an alternate class of LTs synthesized by a pathway involving the dual actions of 15- and 12-LOs on arachidonic acid via 15-HpETE and 14,15-LTA4 intermediates. These metabolites are classified as eoxins because they are formed mostly by eosinophils. Mast cells and nasal polyps can synthesize 14,15-LTC4 as well, however metabolism to 14,15-LTE4 in these cells and tissue has not been documented. 14,15-LTE4 increases vascular permeability of human endothelial cell monolayers with about 10-fold less potency than LTC4, but approximately 100-fold greater potency than histamine.
成立日期 | 2014-06-05 (11年) | 注冊資本 | 100 |
員工人數(shù) | 50-100人 | 年營業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,抗體,細胞培養(yǎng),分子生物學,免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥5149.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2025-01-20 | |
詢價 |
VIP6年
|
湖北惠擇普醫(yī)藥科技有限公司
|
2025-01-12 | |
詢價 |
VIP4年
|
武漢艾美捷科技有限公司
|
2024-12-20 | |
¥2310 |
VIP3年
|
TargetMol中國(陶術(shù)生物)
|
2024-12-12 |